Literature DB >> 1525154

Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes.

K D Parris1, D J Hoover, D B Damon, D R Davies.   

Abstract

The crystal structures of rhizopuspepsin complexed with two oligopeptide inhibitors have been determined. CP-69,799, an azahomostatine dipeptide isostere, had previously been associated with a displacement of the C-terminal subdomain of endothiapepsin [Sali, A., Veerapandian, B., Cooper, J. B., Foundling, S. I., Hoover, D. J., & Blundell, T. L. (1989) EMBO J. 8, 2179-2188]. Here, we report the measurement of two data sets, one from crystals soaked in the inhibitor and the other from protein crystallized in the presence of excess inhibitor. In neither case is there any significant movement of the C-terminal subdomain of the rhizopuspepsin. The data suggest that the energy associated with any conformational change is small and is overcome by the crystal packing forces. The second inhibitor, a hydrated difluorostatone, was examined in a search for transition-state analogs that could cast further light on the mechanism of action [Suguna, K., Padlan, E. A., Smith, C. W., Carlson, W. D., & Davies, D. R. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 7009-7013]. The gem-diol provides a set of contact distances with the enzyme that mimic the interactions with the tetrahedral intermediate of the substrate during catalysis. These data provide support for the suggestion that the polarization of the keto group of the peptide substrate is enhanced by a hydrogen bond from the OD1 of Asp 35 (Suguna et al., 1987).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525154     DOI: 10.1021/bi00150a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

Authors:  W H Martin; D J Hoover; S J Armento; I A Stock; R K McPherson; D E Danley; R W Stevenson; E J Barrett; J L Treadway
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.

Authors:  Kishore Viswanathan; Dennis J Hoover; Jeannie Hwang; Meagan L Wisniewski; Uzoma S Ikonne; Ben A Bahr; Dennis L Wright
Journal:  ACS Med Chem Lett       Date:  2012-09-09       Impact factor: 4.345

4.  Penicillopepsin-JT2, a recombinant enzyme from Penicillium janthinellum and the contribution of a hydrogen bond in subsite S3 to k(cat).

Authors:  Q N Cao; M Stubbs; K Q Ngo; M Ward; A Cunningham; E F Pai; G C Tu; T Hofmann
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

5.  Mechanism of action of aspartic proteinases: application of transition-state analogue theory.

Authors:  S Ołdziej; J Ciarkowski
Journal:  J Comput Aided Mol Des       Date:  1996-12       Impact factor: 3.686

6.  Assigning the protonation states of the key aspartates in β-Secretase using QM/MM X-ray structure refinement.

Authors:  Ning Yu; Seth A Hayik; Bing Wang; Ning Liao; Charles H Reynolds; Kenneth M Merz
Journal:  J Chem Theory Comput       Date:  2006       Impact factor: 6.006

7.  Engineering the substrate specificity of rhizopuspepsin: the role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in P1.

Authors:  W T Lowther; P Majer; B M Dunn
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.